Ananias C. Diokno

Ananias C. Diokno

Auto-generated profile, based on publicly available information

Ananias C. Diokno

William Beaumont Hospital

Research Focus & Metrics

Academic Career Length

56Years (1971-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 1975 in Urology
Verified
Journal Article
Closed access
ADAnanias C. Diokno
Ananias C. Diokno
MTMarc Taub
Marc Taub

1 January 1990 in Archives of internal medicine (1960)
Verified
Journal Article
Closed access
PDF file
ADAnanias C. Diokno
Ananias C. Diokno
MBMorton B. Brown
Morton B. Brown
AHA. Regula Herzog
A. Regula Herzog
Research from JAMA Internal Medicine — Sexual Function in the Elderly

1 March 2004 in Journal of Urology
Verified
Journal Article
Closed access
ADAnanias C. Diokno
Ananias C. Diokno
CSCarolyn M. Sampselle
Carolyn M. Sampselle
AHA. Regula Herzog
A. Regula Herzog
TRT.E. Raghunathan
T.E. Raghunathan
SHSandra Hines
Sandra Hines
MLMaria Claudia A. Leite
Maria Claudia A. Leite
We determined whether a behavioral modification program (BMP) taught to groups of continent older women would decrease the incidence of urinary incontinence, increase pelvic muscle strength and improve voiding control. We performed a randomized, controlled trial comparing a BMP treatment group to a control, no treatment group in ambulatory, postmenopausal, continent women (0 to 5 days of incontinent episodes in the previous year) 55 years and older who were followed for 12 months. Qualified volunteers from 4 Michigan counties were randomly assigned to a control or a treatment group, consisting of a 2-hour classroom presentation on BMP followed 2 to 4 weeks later with individualized evaluation to test knowledge, adherence and skills in behavioral techniques, and brief reinforcement of the technique as needed. Followup was done by telephone and mail every 3 months except month 12, when all participants underwent final clinical evaluation. Outcome measures were continence status, pelvic floor muscle strength and voiding frequency/intervoid interval. A total of 195 control and 164 treated participants completed the study. Baseline data on the 2 groups were not statistically different. At 12 months the treatment group was statistically significantly better than the control group in continence status (p = 0.01), pelvic muscle strength (pressure score p = 0.0003 and displacement score p <0.0001), improved voiding frequency (p <0.0001) and intervoid interval (p <0.0001). To our knowledge we report the first randomized, controlled trial of BMP for preventing urinary incontinence in older women. It demonstrated feasibility and efficacy in improving continence status, pelvic muscle strength and voiding control as long as a year after treatment.

4 April 2006 in Family Practice
Verified
Journal Article
Open access
PDF file
ADAnanias C Diokno
Ananias C Diokno
PSPeter K Sand
Peter K Sand
SMScott Macdiarmid
Scott Macdiarmid
RSRajul Shah
Rajul Shah
RARobert B Armstrong
Robert B Armstrong
Objectives. To evaluate women's perceptions about bladder control problems. Methods. 757 women with one or more bladder control symptoms (frequency, urgency, stress or urge urinary incontinence and nocturia) participated in an Internet-based survey. A separate study involved 12 focus groups including a total of 180 women with bladder control problems. Results. Respondents in the survey reported multiple symptoms, e.g. stress urinary incontinence (72%), frequency (56%), nocturia (45%), urge urinary incontinence (43%) and urgency (33%). Women in both the survey and the focus groups revealed extensive use of coping mechanisms to manage their symptoms. The focus groups revealed that many women were not aware that overactive bladder (OAB) is a pathophysiological condition. Approximately 30% of respondents in the survey felt uncomfortable talking to their doctor about their condition. Among women who did speak with their doctor, stress-related symptoms were described more readily than urge-related symptoms. In the survey, only about half (56%) of the women felt their OAB medication was effective, and half (50%) stopped taking their medication at some point. Information from the focus groups suggested that some women may have unrealistic expectations of onset of efficacy or extent of benefit and may be unprepared for managing side effects. Conclusions. Feelings of embarrassment and limited understanding of the pathophysiology of OAB can contribute to miscommunication between a woman and her doctor. Patient education regarding reasonable expectations coupled with suggestions for coping with unwanted side effects will likely result in better management.

31 July 1984 in Urology
Verified
Journal Article
Closed access
CBCarol J. Bennett
Carol J. Bennett
ADAnanias C. Diokno
Ananias C. Diokno

1 July 1977 in Urology
Verified
Journal Article
Closed access
ADAnanias C. Diokno
Ananias C. Diokno
JLJack Lapides
Jack Lapides